Dr. Susan Mathai, MD
Claim this profileBaylor Scott & White Research Institute
Studies Pulmonary Fibrosis
Studies Fibrosis
5 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Susan Mathai, MD is currently running
Ifetroban
for Pulmonary Fibrosis
Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF.
Recruiting0 awards Phase 26 criteria
Oral Ifetroban
for Scleroderma
This trial is testing ifetroban, an oral medication, in patients with severe forms of systemic sclerosis. The goal is to see if it can reduce inflammation and improve blood flow, potentially helping to manage their condition better.
Recruiting0 awards Phase 22 criteria
More about Susan Mathai, MD
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Susan Mathai, MD has experience with
- Placebo
- Saracatinib
- Nintedanib
- Ifetroban
- Oral Placebo
- Patient Biospecimen Registry
Breakdown of trials Susan Mathai, MD has run
Pulmonary Fibrosis
Fibrosis
Idiopathic Pulmonary Fibrosis
Lung Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Susan Mathai, MD specialize in?
Susan Mathai, MD focuses on Pulmonary Fibrosis and Fibrosis. In particular, much of their work with Pulmonary Fibrosis has involved Envisia genomic classifier positive patients, or patients who are undergoing treatment.
Is Susan Mathai, MD currently recruiting for clinical trials?
Yes, Susan Mathai, MD is currently recruiting for 2 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Susan Mathai, MD has studied deeply?
Yes, Susan Mathai, MD has studied treatments such as Placebo, Saracatinib, Nintedanib.
What is the best way to schedule an appointment with Susan Mathai, MD?
Apply for one of the trials that Susan Mathai, MD is conducting.
What is the office address of Susan Mathai, MD?
The office of Susan Mathai, MD is located at: Baylor Scott & White Research Institute, Dallas, Texas 75246 United States. This is the address for their practice at the Baylor Scott & White Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.